Fernando Pedro de Souza-Neto1, Melissa Carvalho Santuchi1, Mario de Morais E Silva1, Maria José Campagnole-Santos1, Rafaela Fernandes da Silva2. 1. Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Antônio Carlos. 6627, Pampulha, Belo Horizonte, MG, 31270-901, Brazil. 2. Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Antônio Carlos. 6627, Pampulha, Belo Horizonte, MG, 31270-901, Brazil. rfdasilva.ufmg@gmail.com.
Abstract
PURPOSE OF REVIEW: The purpose of this review was to summarize the current knowledge on the role of angiotensin-(1-7) [Ang-(1-7)] and alamandine in experimental hypertension and atherosclerosis. RECENT FINDINGS: The renin-angiotensin system (RAS) is a very complex system, composed of a cascade of enzymes, peptides, and receptors, known to be involved in the pathogenesis of hypertension and atherosclerosis. Ang-(1-7), identified and characterized in 1987, and alamandine, discovered 16 years after, are the newest two main effector molecules from the RAS, protecting the vascular system against hypertension and atherosclerosis. While the beneficial effects of Ang-(1-7) have been widely studied in several experimental models of hypertension, much less studies were performed in experimental models of atherosclerosis. Alamandine has shown similar vascular effects to Ang-(1-7), namely, endothelial-dependent vasorelaxation mediated by nitric oxide and hypotensive effects in experimental hypertension. There are few studies on the effects of alamandine on atherosclerosis.
PURPOSE OF REVIEW: The purpose of this review was to summarize the current knowledge on the role of angiotensin-(1-7) [Ang-(1-7)] and alamandine in experimental hypertension and atherosclerosis. RECENT FINDINGS: The renin-angiotensin system (RAS) is a very complex system, composed of a cascade of enzymes, peptides, and receptors, known to be involved in the pathogenesis of hypertension and atherosclerosis. Ang-(1-7), identified and characterized in 1987, and alamandine, discovered 16 years after, are the newest two main effector molecules from the RAS, protecting the vascular system against hypertension and atherosclerosis. While the beneficial effects of Ang-(1-7) have been widely studied in several experimental models of hypertension, much less studies were performed in experimental models of atherosclerosis. Alamandine has shown similar vascular effects to Ang-(1-7), namely, endothelial-dependent vasorelaxation mediated by nitric oxide and hypotensive effects in experimental hypertension. There are few studies on the effects of alamandine on atherosclerosis.
Entities:
Keywords:
Alamandine; Angiotensin-(1–7); Atherosclerosis; Mas receptor; MrgD receptor; hypertension; Renin-angiotensin system
Authors: Nívia M Santiago; Priscila S Guimarães; Raquel A Sirvente; Laser A M Oliveira; Maria C Irigoyen; Robson A S Santos; Maria J Campagnole-Santos Journal: Hypertension Date: 2010-03-08 Impact factor: 10.190
Authors: Álvaro P S Souza; Deny B S Sobrinho; Jônathas F Q Almeida; Gisele M M Alves; Larissa M Macedo; Juliana E Porto; Eneida F Vêncio; Diego B Colugnati; Robson A S Santos; Anderson J Ferreira; Elizabeth P Mendes; Carlos H Castro Journal: Clin Sci (Lond) Date: 2013-11 Impact factor: 6.124
Authors: Bo Dong; Cheng Zhang; Jing Bo Feng; Yu Xia Zhao; Shu Ying Li; Ya Pei Yang; Qiu Li Dong; Bi Ping Deng; Li Zhu; Qing Tao Yu; Chun Xi Liu; Bin Liu; Chun Ming Pan; Huai Dong Song; Ming Xiang Zhang; Yun Zhang Journal: Arterioscler Thromb Vasc Biol Date: 2008-04-10 Impact factor: 8.311
Authors: Analina R Silva; Edenil C Aguilar; Jacqueline I Alvarez-Leite; Rafaela F da Silva; Rosa M E Arantes; Michael Bader; Natalia Alenina; Graziano Pelli; Sébastien Lenglet; Katia Galan; Fabrizio Montecucco; François Mach; Sérgio H S Santos; Robson A S Santos Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-10-02 Impact factor: 3.619
Authors: Jacek Jawien; Justyna Toton-Zuranska; Katarzyna Kus; Malgorzata Pawlowska; Rafal Olszanecki; Ryszard Korbut Journal: Med Sci Monit Date: 2012-10
Authors: Siarhei A Dabravolski; Alexander M Markin; Elena R Andreeva; Ilya I Eremin; Alexander N Orekhov; Alexandra A Melnichenko Journal: Int J Mol Sci Date: 2022-10-01 Impact factor: 6.208